Skip to main content
$10.57 $0.09 (0.9%)

04:00 PM EST on 01/15/21

Pain Therapeutics Inc (NASDAQ:SAVA)

CAPS Rating: 1 out of 5

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Current Price $10.57 Mkt Cap $369.5M
Open $10.38 P/E Ratio 0.00
Prev. Close $10.57 Div. (Yield) $0.00 (0.0%)
Daily Range $9.98 - $10.99 Volume 2,297,434
52-Wk Range $1.63 - $12.99 Avg. Daily Vol. 2,315,676

Caps

How do you think NASDAQ:SAVA will perform against the market?

Add Stock to CAPS Watchlist

All Players

170 Outperform
29 Underperform
 

All-Star Players

19 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SAVA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Simbalion200 (< 20)
Submitted April 09, 2010

Pain Therapeutics, Inc. is a biopharmaceutical company that develops drugs. As of December 31, 2009, the Company had four drug candidates in clinical programs, including REMOXY, PTI-202, PTI-721 and a radio-labeled monoclonal antibody to treat… More

SmartAce (99.60)
Submitted August 27, 2018

My 5 year old son just asked “what if we put a slice of turkey in the DVD player and it played a movie about the turkey’s whole life” and none of the parenting books I’ve read have prepared me for this question.

Recent Community Commentary

Read the most recent pitches from players about SAVA.

Recs

0
Member Avatar capptten (< 20) Submitted: 11/30/2020 8:05:16 PM : Outperform Start Price: $7.66 NASDAQ:SAVA Score: +35.22

This is a high risk high reward stock. The company has changed the name to Cassava Science. The have completed a stage 2 study and raised and additional 75 million to bring cash up to about 94 million. This will allow them to do a stage 3 study which they will be meeting the FDA in January. The stage 2 showed improved many improved biomarkers and there were some stories of caregivers noticing improvement in some patients behaviors. All of this information is readily available. The company decided to raise the money to complete more studies than sell the at a discounted price. If this study goes well most feel that this company would be bought out in excess of $100 per share. I encourage you to read and do your own DD.

Recs

0
Member Avatar OklaBoston (55.67) Submitted: 9/6/2019 4:21:04 PM : Outperform Start Price: $9.45 NASDAQ:SAVA Score: -3.50

SAVA bottoming out at less than 1/5 of it's 2 year high.

Recs

0
Member Avatar TerryHogan (99.81) Submitted: 10/12/2018 1:41:05 AM : Underperform Start Price: $1.36 NASDAQ:SAVA Score: -641.46

I generally like to look at cash flow statements before making a decision. But there's not a whole lot to be gained from studying these. Zero revenue. Red Thumb.

Leaderboard

Find the members with the highest scoring picks in SAVA.

Score Leader

medeaschild

medeaschild (< 20) Score: +1,230.29

The Score Leader is the player with the highest score across all their picks in SAVA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
medeaschild < 20 12/26/2018 Outperform NS $0.76 +1,289.51% +59.22% +1,230.29 0 Comment
marcet 73.65 3/2/2009 Underperform 3W $18.82 -43.85% +427.25% +471.10 0 Comment
foolrrrrrrrrrr 46.59 11/13/2008 Underperform 1Y $37.61 -71.89% +356.12% +428.02 0 Comment
hackerbobZ < 20 3/23/2009 Underperform 5Y $17.65 -40.12% +382.12% +422.25 0 Comment
Dennyf10 59.21 10/16/2008 6/22/2009 Underperform 1Y $35.72 -70.41% +321.06% +391.48 0 Comment
deemonfather42 < 20 7/6/2009 Underperform 3W $22.42 -52.86% +322.13% +374.98 0 Comment
kozmo66 < 20 9/22/2008 Underperform 3M $38.69 -72.68% +209.38% +282.06 0 Comment
martijnvanwerde 95.82 10/19/2006 Underperform 3M $35.60 -70.31% +192.48% +262.78 0 Comment
TheDecider 33.79 1/27/2011 Underperform 5Y $34.90 -69.72% +189.33% +259.05 0 Comment
Whereismymony < 20 12/8/2006 Underperform 3M $36.27 -70.86% +182.61% +253.47 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SAVA.